{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:11:18Z","timestamp":1760955078405,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.metabol.2008.01.033","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T12:52:09Z","timestamp":1221742329000},"page":"1323-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Naoya","family":"Fukunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Anan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunori","family":"Saikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2008.01.033_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1523-1755.2003.00101.x","article-title":"Elevated risk of stroke among patients with end-stage renal disease","volume":"64","author":"Seliger","year":"2003","journal-title":"Kindey Int"},{"key":"10.1016\/j.metabol.2008.01.033_bib2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ki.1993.352","article-title":"Evidence for high risk of cerebral hemorrhage in chronic dialysis patients","volume":"44","author":"Iseki","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2008.01.033_bib3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/ki.1996.484","article-title":"Predictors of stroke in patients receiving chronic hemodialysis","volume":"50","author":"Iseki","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2008.01.033_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000068034","article-title":"Silent cerebral infarction in hemodialysis patients","volume":"23","author":"Nakatani","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2008.01.033_bib5","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/j.1523-1755.2005.00351.x","article-title":"Silent cerebral infarction predicts vascular events in hemodialysis patients","volume":"67","author":"Naganuma","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2008.01.033_bib6","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/S0021-9258(18)32663-2","article-title":"Human plasma lipoprotein (a): structural properties","volume":"258","author":"Gaubatz","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2008.01.033_bib7","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2008.01.033_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study","volume":"37","author":"Ohira","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2008.01.033_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stoke. A meta-analysis of observational studies","volume":"38","author":"Smolders","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2008.01.033_bib10","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1046\/j.1523-1755.1999.07164.x","article-title":"Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients","volume":"71","author":"Ohashi","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2008.01.033_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1681\/ASN.V61110","article-title":"Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis","volume":"6","author":"Kronenberg","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2008.01.033_bib12","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.STR.28.10.1932","article-title":"Subcortical silent cerebral infarction as a risk factor for clinical stroke","volume":"28","author":"Kobayashi","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2008.01.033_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.32.8.871","article-title":"Lacunar strokes and infarcts","volume":"32","author":"Fisher","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.metabol.2008.01.033_bib14","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/diacare.21.12.2116","article-title":"Multiple metabolic syndrome is associated with lower rate variability","volume":"21","author":"Liao","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2008.01.033_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cca.2006.05.018","article-title":"Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus","volume":"373","author":"Wakabayashi","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2008.01.033_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2007.08.007","article-title":"High-sensitivity C-reactive protein is a significant risk factor for silent cerebral infarction in patients on hemodialysis","volume":"57","author":"Anan","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2008.01.033_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.STR.0000069163.02611.B0","article-title":"MTHFR gene polymorphism as a risk factor for silent brain infracts and white matter lesions in the Japanese general population. The NILS-LSA study","volume":"34","author":"Kohara","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2008.01.033_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2214\/ajr.151.3.551","article-title":"Pathologic correlation with gross and histopathology, 1: lacunar infarction and Virchow-Robin spaces","volume":"151","author":"Braffman","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.metabol.2008.01.033_bib19","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa001066","article-title":"Cardiovascular investigators: Lp(a) Lipoprotein, vascular disease, and mortality in the elderly","volume":"349","author":"Ariyo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2008.01.033_bib20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/clinchem\/45.7.1039","article-title":"Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham study","volume":"45","author":"Seman","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2008.01.033_bib21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.96.5.1390","article-title":"Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women","volume":"96","author":"Nguyen","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2008.01.033_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0735-1097(97)00528-7","article-title":"Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study","volume":"31","author":"Cantin","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2008.01.033_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00043798-199808000-00010","article-title":"Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Healthy Study","volume":"5","author":"Ariyo","year":"1998","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.metabol.2008.01.033_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0735-1097(97)00497-X","article-title":"Does lipoprotein(a) impair endothelial function?","volume":"31","author":"Schlaich","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2008.01.033_bib25","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0735-1097(98)00469-0","article-title":"Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation","volume":"32","author":"Dangas","year":"1998","journal-title":"J Am Coll Cardiol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049508000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:32:22Z","timestamp":1758425542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049508000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0026049508000668"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2008.01.033","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2008.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}